Roivant Sciences (ROIV) EPS (Basic) (2020 - 2026)
Roivant Sciences' (ROIV) quarterly EPS (Basic) came in at $0.52 in Q4 2024, up 282.4% YoY from $0.14 in Q1 2024, and up 981.49% on a QoQ basis from -$0.06 in Q3 2024.
Powered by 
Analysis
Roivant Sciences (ROIV) EPS (Basic) (2020 - 2026) Analysis & Trends
Roivant Sciences (ROIV) has 5 years of EPS (Basic) data on file, last reported at $0.52 in Q4 2024.
- Quarterly EPS (Basic) rose 282.4% year-over-year to $0.52 in Q4 2024, while the trailing twelve-month figure through Sep 2025 was $0.55 (up 323.14% YoY) and the FY2025 annual result came in at $0.51, up 227.86% from the prior year.
- EPS (Basic) advanced to $0.52 in Q4 2024, from -$0.06 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.52 in Q4 2024 to a low of -$1.48 in Q4 2022.
- A 5-year average of -$0.33 and a median of -$0.35 in 2021 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2021 — EPS (Basic) slumped 1126.02% — and 2024, when it surged 282.4%.
- Tracing ROIV's EPS (Basic) over 5 years: stood at -$0.44 in 2020, then tumbled by 110.58% to -$0.92 in 2021, then tumbled by 60.41% to -$1.48 in 2022, then jumped by 80.85% to -$0.28 in 2023, then surged by 282.4% to $0.52 in 2024.
- The last three EPS (Basic) figures came in at $0.52 (Q4 2024), -$0.06 (Q3 2024), and $0.12 (Q2 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | -3.06 |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 0.18 |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | -0.06 |
| 10 | Roivant Sciences | 24.94 Bn | 24.94 Bn | 1.16 Mn | -0.40 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.40 |
| Dec 31, 2025 | -1.08 |
| Sep 30, 2025 | -0.24 |
| Jun 30, 2025 | -0.40 |
| Dec 31, 2024 | -0.11 |
| Sep 30, 2024 | -0.38 |
| Jun 30, 2024 | 0.08 |
| Dec 31, 2023 | 6.12 |
| Sep 30, 2023 | -0.43 |
| Jun 30, 2023 | -0.43 |
| Dec 31, 2022 | -1.48 |
| Sep 30, 2022 | -0.45 |
| Jun 30, 2022 | -0.51 |
| Dec 31, 2021 | -0.92 |
| Sep 30, 2021 | -0.35 |
| Jun 30, 2021 | -0.46 |
| Dec 31, 2020 | -0.44 |
| Sep 30, 2020 | -0.09 |
| Jun 30, 2020 | -0.04 |